Neutral
Johnson & Johnson proposes $5.5 billion talc settlement to end lawsuits.
Johnson & Johnson has proposed a $5.5 billion settlement to resolve approximately 76,000 lawsuits alleging that its talc products caused ovarian cancer. This move aims to conclude over a decade-long legal battle, contingent upon at least 95% of claimants accepting the offer. The company plans to make an initial payment of up to $3 billion in 2027, with no further payments due until 2028.
Key points
- Shares rose over 2% before markets opened following the settlement announcement.
- The settlement is contingent upon participation from at least 95% of the remaining claimants.
- Johnson & Johnson plans to make an initial payment of up to $3 billion in 2027, with no further payments due until 2028.
Sources
AI-generated from public news sources. Not financial advice.
